Stuttgart - Delayed Quote EUR
KalVista Pharmaceuticals Inc (4XC1.SG)
10.90
0.00
(0.00%)
As of 8:04:18 AM GMT+2. Market Open.
Loading Chart for 4XC1.SG
- Previous Close
10.90 - Open
10.90 - Bid 10.90 x --
- Ask 11.20 x --
- Day's Range
10.90 - 10.90 - 52 Week Range
7.10 - 14.40 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Jul 9, 2025 - Jul 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 4XC1.SG
View MorePerformance Overview: 4XC1.SG
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
4XC1.SG
36.25%
S&P 500 (^GSPC)
4.67%
1-Year Return
4XC1.SG
1.80%
S&P 500 (^GSPC)
8.08%
3-Year Return
4XC1.SG
3.33%
S&P 500 (^GSPC)
35.98%
5-Year Return
4XC1.SG
15.96%
S&P 500 (^GSPC)
94.60%
Compare To: 4XC1.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4XC1.SG
View MoreValuation Measures
As of 5/5/2025
Market Cap
576.30M
Enterprise Value
357.36M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
4.45
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--